- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02260219
Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
Comparative Study of the Safety and Efficacy of the Ahmed Glaucoma Valve Drainage Device, Model M4 (High Density Porous Polyethylene) and the Model S2 (Polypropylene) in Patients With Neovascular Glaucoma
Objective: Prospectively evaluate the safety and efficacy of the Ahmed Glaucoma Drainage Device, model M4 compared with the model S2.
Method: Mexican patients with Neovascular Glaucoma will be randomly included for each group (M4 and S2). They will be operated using conventional techniques and creating a sub-episcleral tunnel to place the valve's tube in the anterior chamber. They will be monitoring for one year and the results will be evaluated with respect to a postoperative reduction in pressure, changes in visual acuity, the need for drugs and complications, in addition to the demographic characteristics of each group.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with diagnosis of Neovascular glaucoma
- High IOP despite topical treatment
Exclusion Criteria:
- Pregnant women
- Mental disorders
- Previous glaucoma surgery
- Patients older than 18 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: S2
Surgically Implant an Ahmed Glaucoma Drainage Device Model S2 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP
|
Surgically Implant an Ahmed Glaucoma Drainage Device Models S2 and M4, evaluare IOP evolution, complications and need for medication to control IOP
|
Active Comparator: M4
Surgically Implant an Ahmed Glaucoma Drainage Device Model M4 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP
|
Surgically Implant an Ahmed Glaucoma Drainage Device Models S2 and M4, evaluare IOP evolution, complications and need for medication to control IOP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of participants with adverse effects
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Intraocular pressure
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Investigators
- Study Director: Felix Gil-Carrasco, MD, 52 55 10841400
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GL-12-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neovascular Glaucoma
-
Shahid Beheshti University of Medical SciencesCompletedGlaucoma | NeovascularIran, Islamic Republic of
-
University of Colorado, DenverCompletedNeovascular GlaucomaUnited States
-
Cairo UniversityKasr El Aini Hospital; AL-Nour Eye HospitalCompletedNeovascular GlaucomaEgypt
-
Federal University of São PauloUnknown
-
Iran University of Medical SciencesNot yet recruitingNeovascular GlaucomaIran, Islamic Republic of
-
BayerRecruiting
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompletedNeovascular GlaucomaChina
-
Federal University of São PauloWithdrawn
-
University of Illinois at ChicagoGenentech, Inc.WithdrawnGlaucoma | Neovascular Glaucoma | New Onset Glaucoma | New Onset Neovascular Glaucoma
-
University of LuebeckCompletedNeovascular Glaucoma | RubeosisGermany
Clinical Trials on Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2
-
Retina Implant AGCompletedRetinal Degeneration | Retinitis PigmentosaGermany, Hungary, United Kingdom
-
Siriraj HospitalCompletedGlaucoma | Intraocular Pressure | Graft FailureThailand
-
Federal University of São PauloUnknown
-
Singapore Eye Research InstituteNational Medical Research Council (NMRC), SingaporeUnknown
-
University of California, San FranciscoUniversity of Colorado, Denver; University of Maryland; Zhongshan Ophthalmic... and other collaboratorsCompletedPrimary Open Angle Glaucoma | Glaucoma | Neovascular Glaucoma | Secondary GlaucomaUnited States, China, India, Mexico
-
Tema Christian Eye CenterInternational Glaucoma Association; HCA International FoundationUnknown
-
Universidad Complutense de MadridNot yet recruitingPeri-Implantitis